We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

235 hedge funds and large institutions have $263M invested in Editas Medicine in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 65 increasing their positions, 72 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more call options, than puts

Call options by funds: $2.6M | Put options by funds: $1.83M

32% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 37

4% more funds holding

Funds holding: 225 → 235 (+10)

10% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 72

14.47% less ownership

Funds ownership: 83.04% → 68.57% (-14%)

48% less capital invested

Capital invested by funds: $504M → $263M (-$240M)

Holders
235
Holders Change
+10
Holders Change %
+4.44%
% of All Funds
3.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
65
Reduced
72
Closed
37
Calls
$2.6M
Puts
$1.83M
Net Calls
+$777K
Net Calls Change
-$2.08M

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$4.61M
2
APM
Avidity Partners Management
Texas
+$4.6M
3
DTC
Deep Track Capital
Connecticut
+$2.67M
4
HF
HRT Financial
New York
+$1.68M
5
TI
Trexquant Investment
Connecticut
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$23.5M
2
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$7.76M
3
Morgan Stanley
Morgan Stanley
New York
-$4.88M
4
Two Sigma Investments
Two Sigma Investments
New York
-$4.78M
5
Pictet Asset Management
Pictet Asset Management
Switzerland
-$4.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
National Bank of Canada
151
National Bank of Canada
Quebec, Canada
$14.2K +$1.58K +280 +10%
AB
152
Amalgamated Bank
New York
$13K – – –
Mirae Asset Global Investments
153
Mirae Asset Global Investments
South Korea
$11.6K -$1.76M -312,319 -99%
Nisa Investment Advisors
154
Nisa Investment Advisors
Missouri
$8.62K +$1.85K +328 +22%
WWP
155
WR Wealth Planners
Missouri
$7.82K -$2.26K -400 -19%
KFS
156
Kelly Financial Services
Massachusetts
$7.63K – – –
S
157
SignatureFD
Georgia
$7.32K +$316 +56 +4%
NA
158
NewEdge Advisors
Louisiana
$7.26K -$1.83K -325 -17%
WIM
159
Westside Investment Management
California
$7.24K -$1.69K -300 -16%
GI
160
GAMMA Investing
California
$7.09K +$4.47K +793 +109%
QCG
161
Quadrant Capital Group
Ohio
$6.59K +$479 +85 +6%
TLCM
162
Twin Lakes Capital Management
California
$5.84K – – –
Pacer Advisors
163
Pacer Advisors
Pennsylvania
$5.71K -$14.2K -2,526 -67%
US Bancorp
164
US Bancorp
Minnesota
$5.62K +$440 +78 +7%
SHIM
165
Stone House Investment Management
Pennsylvania
$4.96K – – –
RFG
166
RFP Financial Group
Georgia
$4.67K +$5.64K +1,000 New
TWC
167
TD Waterhouse Canada
Ontario, Canada
$3.84K -$4.51K -800 -49%
GRP
168
Global Retirement Partners
California
$3.74K +$2.26K +400 +100%
SPIA
169
Steward Partners Investment Advisory
New York
$3.48K +$355 +63 +9%
PMAM
170
Picton Mahoney Asset Management
Ontario, Canada
$3K +$4.74K +841 New
AWM
171
AllSquare Wealth Management
New York
$2.92K – – –
HCM
172
Hollencrest Capital Management
California
$2.87K – – –
AF
173
Advisornet Financial
Minnesota
$2.59K – – –
LC
174
Lindbrook Capital
California
$2.43K +$2.93K +520 New
AWM
175
Ameliora Wealth Management
Switzerland
$2.33K – – –
5 6
7
8 9

EDIT Hedge Fund Activity: Q2 2024 in Review

235 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2024, worth a combined $263M — down 48% from $504M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new EDIT positions and 37 closed out — a net gain of 12 holders — while 65 added to existing stakes and 72 trimmed.

The largest buyer was UBS AM, adding an estimated $4.61M. The largest seller was State Street, cutting an estimated $23.5M.

  • 235 institutional investors held Editas Medicine (EDIT) as of Q2 2024, up from 225 in Q1 2024.
  • Funds reported $263M of Editas Medicine stock for Q2 2024, down 48% quarter-over-quarter.
  • 49 funds opened new Editas Medicine positions in Q2 2024 and 37 closed out, a net change of +12 holders.
  • The largest Editas Medicine buyer in Q2 2024 was UBS AM, an estimated $4.61M added.
  • The largest Editas Medicine seller in Q2 2024 was State Street, an estimated $23.5M sold.

Based on aggregated 13F filings for Q2 2024.